Company / Operating Income per Share
Opus Genetics, Inc. Operating Income per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.97
FY2025
5-year range
-$1.97 / $0.87
FY2021-FY2025
Trend
-346.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -346% YoY in FY2025, a notable deviation from the 6-year average annual change of -582%.
Based on SEC 10-K filings.
-1.97 in FY2025.
Declined from $0.87 to $-1.97 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 346.3% year-over-year.
- Peak operating income per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.97 | -346.3% |
| FY2024 | -$0.44 | -150.4% |
| FY2023 | $0.87 | +172.5% |
| FY2022 | -$1.20 | +34.3% |
| FY2021 | -$1.83 | -3230.6% |
| FY2013 | -$0.06 | +28.3% |
| FY2011 | -$0.08 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026